← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever
Active
- Institution
- Thomas Jefferson University, PA
- Principal investigator
- Maja Sundberg
- Funding
- $3.3M
- Duration
- 2017–2027
Moonbase score
Still being scored
Abstract
To support advanced development of a multivalent vaccine candidates for Filovirus and Lassa Fever. This contract spans formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in nonhuman primates, IND enabling GLP repeated dose toxicology, and submission of an IND. The project is currently supporting a Phase I clinical trial to evaluate the candidate vaccine.
LOADING MOONBASE SCORE
Questions for Thomas Jefferson University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Thomas Jefferson University48
Mechanisms of cell death in cutaneous melanoma
Emad S Alnemri · $478K · 2021–2026
- NIH · Thomas Jefferson University46
Integrated Structural Biology Shared Resource
Gino Cingolani · $1 · 1995–2029
- NIH · Thomas Jefferson University45
Molecular Neurogenetics of the Brainstem Neuronal Source of Cardioprotective Vagal Outflow
James Schwaber · $571K · 2022–2026